Search Results 301-310 of 17569 for what is vedolizumab

  1. Signs and Symptoms of Ulcerative Colitis - Mayo Clinic News Network

    Ulcerative colitis (UL-sur-uh-tiv koe-LIE-tis) symptoms can vary, depending on the severity of inflammation and where it occurs.

  2. A Study to Identify Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease - Mayo Clinic

    A Study to Identify Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease · Overview · Participation eligibility · Participating Mayo Clinic locations.

  3. A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) - Mayo Clinic

    A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction Therapy in Patients with Moderately to Severely Active Crohn's Disease (UNITI-2) · Overview.

  4. Study Shows Crohn's Disease Patients Benefit From Infliximab Plus Azathioprine - Mayo Clinic News Network

    This study represents the first time longer term outcome data has been available to show the advantages of the combination therapy and IFX monotherapy. Crohn's ...

  5. Assessing the prevalence and impact of obesity among individuals with Crohn's disease - Mayo Clinic

    In a population-based study of individuals with newly diagnosed Crohn's disease (CD), researchers analyzed the prevalence of obesity and whether it affects ...

  6. A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's Disease - Mayo Clinic

    Clinical Trials · A Study to Evaluate Long-Term Safety and Effectiveness of HUMIRA (Adalimumab) in Pediatric Patients with Moderately to Severely Active Crohn's ...

  7. Rectovaginal fistula - Symptoms and causes - Mayo Clinic

    The second most common cause of rectovaginal fistulas is Crohn's disease and, more rarely, ulcerative colitis. These inflammatory bowel diseases cause ...

  8. Safety and Efficacy of GS-5745 in Participants With Moderately to Severely Active Crohn's Disease - Mayo Clinic

    This study will primarily evaluate the safety and efficacy of GS-5745 in adults with active Crohn's disease. The study will consist of a Blinded Treatment ...

  9. A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC) - Mayo Clinic

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Vixarelimab in Participants With Moderate to Severe Ulcerative Colitis (UC). Print details.

  10. Etrasimod (oral route) - Side effects & dosage - Mayo Clinic

    Description. Etrasimod is used to treat moderate to severe active ulcerative colitis. This medicine is available only with your doctor's prescription. This ...